Eurofins | Transplant Diagnostics

Your Partner for Every Step of the Transplant Journey

From donor to recipient, the transplant journey requires the right testing at the right time. That’s exactly what we deliver. Diagnostics that inform, monitor and lead to predictive analysis for patients and clinicians seeking personalized insights that can answer life and organ saving transplant questions.

Webinar: November 16
Eurofins Viracor Podcast

For Hematology/Oncology patients the ExPeCT anti-CD19 (FMC63) CAR T assay provides interventional data which may provide information on the expansion and persistence of the genetically modified T-cells used as therapeutic treatment for specific lymphomas and leukemias (Chimeric Antigen Receptor T-cell therapy or CAR T). Eurofins Viracor has developed and validated a multiplexed quantitative real-time PCR (qPCR) assay targeting FMC63 for the longitudinal monitoring of CD19-directed CAR T-cell therapy.

Case Studies

Explore case studies featuring CMV inSIGHT™ T Cell Immunity testing.

Evaluate Neutropenic Transplant Recipient with CMV inSIGHT™ T Cell Immunity

Molecular Biomarkers Guide Treatment and Prevent Rejection in Graft Monitoring

Long-Term Monitoring of Graft Health

Please provide some basic information to access this content.